Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Will antimicrobial resistance of BRD pathogens impact BRD management in the future?

View through CrossRef
AbstractResistance is a qualitative interpretation of antimicrobial activity in vitro. Critical to management of bovine respiratory disease (BRD) is the clinical response in vivo. Attempts to connect activity in vitro to response in vivo have been complicated by the complexity of BRD, interpretation of antimicrobial activity in vitro, and inconsistent measures of clinical success or failure. During recent history, the discovery, development, and commercialization of antimicrobials have decreased. In response to resistance, voluntary and imposed restrictions on use of antimicrobials have been implemented. Resistance can be reversed using technology and knowledge of mechanisms of resistance. Perhaps approaches that reverse resistance will be used in clinical management of BRD in the future. The short answer to the question posed in the title is, ‘yes.’ Since antimicrobial drugs were discovered, resistance has been a consideration for selection of treatment of any infectious disease and BRD is not unique. In the opinion of the author, the more important question is, ‘How will antimicrobial resistance of BRD pathogens impact BRD management in the future?’
Cambridge University Press (CUP)
Title: Will antimicrobial resistance of BRD pathogens impact BRD management in the future?
Description:
AbstractResistance is a qualitative interpretation of antimicrobial activity in vitro.
Critical to management of bovine respiratory disease (BRD) is the clinical response in vivo.
Attempts to connect activity in vitro to response in vivo have been complicated by the complexity of BRD, interpretation of antimicrobial activity in vitro, and inconsistent measures of clinical success or failure.
During recent history, the discovery, development, and commercialization of antimicrobials have decreased.
In response to resistance, voluntary and imposed restrictions on use of antimicrobials have been implemented.
Resistance can be reversed using technology and knowledge of mechanisms of resistance.
Perhaps approaches that reverse resistance will be used in clinical management of BRD in the future.
The short answer to the question posed in the title is, ‘yes.
’ Since antimicrobial drugs were discovered, resistance has been a consideration for selection of treatment of any infectious disease and BRD is not unique.
In the opinion of the author, the more important question is, ‘How will antimicrobial resistance of BRD pathogens impact BRD management in the future?’.

Related Results

Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract Introduction Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Electronic feeding behavioural data as indicators of health status in dairy calves
Electronic feeding behavioural data as indicators of health status in dairy calves
AbstractThe objectives of this study were (i) to characterise clinical health in dairy calves on an Irish research farm during the artificial calf-rearing period and (ii) to determ...
CSIG-24. EPIGENETIC SUPPRESSION ALLOWS GBM TO MAINTAIN P53 WILD-TYPE STATUS
CSIG-24. EPIGENETIC SUPPRESSION ALLOWS GBM TO MAINTAIN P53 WILD-TYPE STATUS
Abstract Introduction Glioblastoma (GBM) is the most common primary brain malignancy in adults. The vast majority of GBM cases m...
Knowledge and Beliefs about Antimicrobial drug resistance and its Implications in Future Prescribers
Knowledge and Beliefs about Antimicrobial drug resistance and its Implications in Future Prescribers
Background & Objective: Antimicrobial drug resistance is the ability of microorganisms to persist or grow in the presence of antimicrobial drugs designed to inhibit or kill the...
Phenotypic and Molecular Characterization of the blaTEM Gene in Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae
Phenotypic and Molecular Characterization of the blaTEM Gene in Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae
Abstract Introduction There has been a notable rise in antibiotic resistance among enterobacteria. This issue is primarily attributed to the emergence of extended-spectrum beta-lac...

Back to Top